跳至主要内容
临床试验/NCT02750228
NCT02750228已完成不适用

Patent Ductus Arteriosus Post NICU Discharge in Premature Infants: A Prospective Registry

Pediatrix16 个研究点 分布在 1 个国家目标入组 208 人开始时间: 2016年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Pediatrix
入组人数
208
试验地点
16
主要终点
Number of subjects that have a report of a spontaneous closure of PDA, medication intervention for closure of PDA or surgical intervention for closure of PDA

研究概览

简要总结

The purpose of this study is to track post-discharge outcomes on prematurely born infants who are discharged from the NICU with a patent ductus arteriosus (PDA). Investigators plan to report on the spontaneous closure rate as well as the incidence of pulmonary and/or cardiac events in these infants. The goal is to identify risk factors associated with adverse outcomes in prematurely born infants who are sent home with a PDA.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
22 Weeks 至 32 Weeks(Child)
性别
All
接受健康志愿者

入选标准

  • Documentation of informed consent and authorization for participation.
  • Estimated gestational age of 32 weeks or less.
  • Active diagnosis of a PDA at discharge.
  • At least one echocardiogram obtained during hospital stay documenting/ confirming PDA diagnosis.
  • Parental agreement to provide follow-up information on their child.
  • Cardiologist and/or Pediatrician willing to provide follow-up information on enrolled infants.

排除标准

  • No known major congenital anomalies (inborn error of metabolism, cyanotic congenital heart disease, gastroschisis, omphalocele, diaphragmatic hernia or other major gastrointestinal anomalies, major neurological injury or anomaly, multiple congenital anomalies).
  • Chromosomal / genetic disorders - Inherited metabolic disorders (Aa, fat or carbohydrate), Trisomies, Turner's syndrome,Vater's syndrome, CHARGE, DiGeorge or other 22q11 deletions, Major chromosomal duplications, deletions detectable on high resolution karyotype (not microarray).
  • Parent(s) unwilling to participate in follow-up.

结局指标

主要结局

Number of subjects that have a report of a spontaneous closure of PDA, medication intervention for closure of PDA or surgical intervention for closure of PDA

时间窗: 18 months

次要结局

  • Number of subjects with or without a closure of PDA that have heart failure, pulmonary arterial hypertension, a need for respiratory support and death(18 months)

研究者

发起方
Pediatrix
申办方类型
Other
责任方
Sponsor

研究点 (16)

Loading locations...

相似试验